Senior Director, Head of Medical Strategy Oncology

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, and a diverse pipeline of early- to late-stage assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.

Job Overview

The Sr Director Oncology Medical Strategy Team Lead will be a key member of the Medical Affairs Leadership team reporting to the Vice President, Medical Affairs.  

The job is responsible for managing the team of Strategy leads for each of the oncology therapeutic areas including pipeline and playing a critical role developing the strategy with each Therapeutic Area Strategy lead and key role with internal company cross functional alignment and external facing interactions. This job will be a key role on the Leadership team and play a highly visible role internally and externally, and effectively lead and communicate with cross-functional team members to develop and execute the strategy.  The role will also collaborate closely with Commercial leadership, as appropriate, and R&D team on strategic initiatives.

Job Duties and Responsibilities

• Support one team, patient first, high energy, positive dynamic culture.
• Aligning with CMO, and VP of MA, to drive medical affairs strategy for Sumitomo Pharma America Inc.
• Provide input to Global/Sumitomo Pharma America Inc. R&D Strategy and other corporate functions. ​
• Provide input to VP Medical Affairs to support budget creation and manage costs to keep within budget of Medical Affairs.
• Lead, develop and mentor team members​.
• Specify, develop and sustain optimal internal processes, capacities and capabilities.
• Develops and aligns Medical Affairs strategic plans with brand strategic imperatives based on external engagement, MSL/cross functional input and impactful insights, supporting data generation, and data communication, education and awareness stakeholders.
• Support alliances, ensuring coordination and alignment of all Medical Affairs activities and budget within SMPA and with alliance partners (were applicable).
• Oversee the strategy and development of Medical Affairs plans and scientific platforms.
• Ensure cross-functional medical alignment with the US Field Medical team, Medical Communications & Operations, RWE & HEOR and ex-US colleagues.
• Direct the implementation of plans that will be executed through multi-modal medical education channels, including publications, presentations, congresses, advisory boards, CME, medical symposia and other channels.
• Oversee the development and implementation of detailed scientific Publication Plans.
• Work with cross functional team to develop and execute Advisory Board.
• External engagement and maintain a highly visible role during exchanges within the medical/scientific community to develop close relationships with a group of scientific key opinion leaders.
• Work closely with the commercial organization to bring the medical perspective to commercial strategies and tactics, aligning with Marketing & Market Access to collaborate on the most efficient and effective ways to work together.
• Define and attend relevant medical and scientific conferences.
• Support strategy and oversight for the development of a supportive US Investigator Initiated Study and Collaborative Research program.
• Ensures that all interactions and activities in the US adhere to corporate and healthcare compliance guidance in all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information.
• Ability to travel (domestic and some international) to attend scientific congresses, participate in internal meetings, and meet key stakeholders in the development of Medical Affairs activities - up to 30% travel